Peters P - Search Results

1

Malignant bowel obstruction due to uterine or ovarian cancer: Are there differences in outcome?

Hoppenot C, Peters P, Cowan M, Moore ED, Hurteau J, Lee NK, Yamada SD. Hoppenot C, et al. Among authors: peters p. Gynecol Oncol. 2019 Jul;154(1):177-182. doi: 10.1016/j.ygyno.2019.04.681. Epub 2019 May 2. Gynecol Oncol. 2019. PMID: 31056111

2

An integrated molecular profile of endometrioid ovarian cancer.

Pierson WE, Peters PN, Chang MT, Chen LM, Quigley DA, Ashworth A, Chapman JS. Pierson WE, et al. Gynecol Oncol. 2020 Apr;157(1):55-61. doi: 10.1016/j.ygyno.2020.02.011. Epub 2020 Mar 3. Gynecol Oncol. 2020. PMID: 32139151 Free article.

3

Cost-effectiveness of management strategies for patients with recurrent ovarian cancer and inoperable malignant bowel obstruction.

Peters PN, Moyett JM, Davidson BA, Cantrell S, Bliss SE, Havrilesky LJ. Peters PN, et al. Gynecol Oncol. 2022 Dec;167(3):523-531. doi: 10.1016/j.ygyno.2022.10.013. Epub 2022 Nov 4. Gynecol Oncol. 2022. PMID: 36344293

4

Guidelines for goals of care discussions in patients with gynecologic cancer.

Peters PN, Havrilesky LJ, Davidson BA. Peters PN, et al. Gynecol Oncol. 2023 Jul;174:247-252. doi: 10.1016/j.ygyno.2023.05.016. Epub 2023 May 25. Gynecol Oncol. 2023. PMID: 37243995 Review.

5

PET-detected asymptomatic recurrence is associated with improved survival in recurrent cervical cancer.

Peters PN, Pierson WE, Chen LM, Westphalen AC, Chapman JS, Hsu IC. Peters PN, et al. Abdom Radiol (NY). 2021 Jan;46(1):341-350. doi: 10.1007/s00261-020-02633-0. Epub 2020 Jul 8. Abdom Radiol (NY). 2021. PMID: 32638077

6

Primary treatment of advanced ovarian cancer: how does the 'real world' practice?

Craig AD, Garcia E, Peters PN, Chen LM, Chapman JS. Craig AD, et al. Future Oncol. 2021 Dec;17(34):4687-4696. doi: 10.2217/fon-2021-0086. Epub 2021 Aug 26. Future Oncol. 2021. PMID: 34435878

7

Local Control and Use of External Beam Parametrial Boost in the Era of Image-Guided Brachytherapy for Locally Advanced Cervical Cancer.

Arya R, Giurcanu M, Jutzy JM, Peters P, Daily EW, Golden DW, McCall AR, Howard AR, Hasan Y, Son CH. Arya R, et al. Among authors: peters p. Am J Clin Oncol. 2021 Nov 1;44(11):565-571. doi: 10.1097/COC.0000000000000863. Am J Clin Oncol. 2021. PMID: 34456239

8

Routine SLN biopsy for endometrial intraepithelial neoplasia: A pragmatic approach or over-treatment?

Peters PN, Rossi EC. Peters PN, et al. Gynecol Oncol. 2023 Jan;168:A2-A3. doi: 10.1016/j.ygyno.2022.12.006. Gynecol Oncol. 2023. PMID: 36577526 No abstract available.

9

Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity.

Peters PN, Schryver EM, Lengyel E, Kenny H. Peters PN, et al. J Vis Exp. 2015 Dec 31;(106):e53541. doi: 10.3791/53541. J Vis Exp. 2015. PMID: 26780294 Free PMC article.

10

Novel Therapies in Gynecologic Cancer.

Bejar FG, Oaknin A, Williamson C, Mayadev J, Peters PN, Secord AA, Wield AM, Coffman LG. Bejar FG, et al. Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-17. doi: 10.1200/EDBK_351294. Am Soc Clin Oncol Educ Book. 2022. PMID: 35594502 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,214 results

Search Page